Erythropoietin as an angiogenic factor
Open Access
- 19 September 2003
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 33 (10) , 891-896
- https://doi.org/10.1046/j.1365-2362.2003.01245.x
Abstract
Erythropoietin (Epo) is produced by the fetal liver and adult kidney and is an essential stimulator of erythropoiesis. It has, however, been shown to modulate host cellular signal transduction pathwa...Keywords
This publication has 68 references indexed in Scilit:
- The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysisKidney International, 2003
- A potential role of erythropoietin in angiogenesis associated with myelodysplastic syndromesLeukemia, 2002
- In vivoactivation of JAK2/STAT‐3 pathway during angiogenesis induced by GM‐CSFThe FASEB Journal, 2001
- Erythropoietin stimulates proliferation of human renal carcinoma cellsKidney International, 2000
- Signal Transduction in the Erythropoietin Receptor SystemExperimental Cell Research, 1999
- Effect of recombinant human erythropoietin on endothelial cell apoptosisKidney International, 1999
- Signal Transduction of Granulocyte Macrophage-Colony Stimulating Factor in a Human Endothelium-Derived Cell Line.The Tohoku Journal of Experimental Medicine, 1997
- Role of angiogenesis in patients with cerebral ischemic stroke.Stroke, 1994
- JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietinCell, 1993
- Cellular sites of extrarenal and renal erythropoietin production in anaemic ratsBritish Journal of Haematology, 1992